Clinical trial
Assessment of the Results of Combined Anterolateral Ligament (ALL) + Antero Crusader Ligament (ACL) Plasty Compared to Classical KJ Plasty in Isolated ACL Ruptures
NCT03740022 is registered in ClinicalTrials.gov with Ascopharm Groupe Novasco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Results of Combined Anterolateral Ligament (ALL) + Antero Crusader Ligament (ACL) Plasty Compared to Classical KJ Plasty in Isolated ACL Ruptures
- Lead sponsor
- Ascopharm Groupe Novasco
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 2, 2016
- Completion date
- June 10, 2024
- Enrollment
- 592 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anterior cruciate ligament injury, ligament rupture